Details on Clenoged 0.04mg

This is a fairly powerful fat burner. In iron sports, Clenoged 0.04mg is mainly used in drying courses, when the athlete is faced with the task of building high-quality muscles (without water retention or fat accumulation). It can be recommended for use in sports for both men and women since the drug is not characterized by gender-specific side effects (androgenic or estrogenic).

The active substance of the drug, Clenbuterol hydrochloride, is a beta-2 adrenostimulator (the mechanism of action is tied to the excitation of beta-2 adrenergic receptors). It does not apply to steroid hormones, respectively, does not have anabolic or androgenic activity. It can indirectly stimulate anabolism, but this effect cannot be called pronounced.

Initially, Clenbuterol preparations, like Clenoged 0.04mg from EPF or its analogues from other manufacturing companies, are medicines. Clen (slang contraction) is used in the treatment of bronchial obstructive syndrome, bronchial asthma, chronic obstructive pulmonary disease. These are official (accepted) indications for use.

In what improvements is the effect of the drug expressed for the athlete? First of all, it contributes to the burning of subcutaneous fat, enhancing metabolism, increasing heat production, mental activation. Also, with systematic administration, an increase in strength indicators, an increase in endurance and acceleration of recovery can be observed.

But Clen is not only an effective fat burner but also an effective anti-catabolic (concerning muscle mass). It is believed that its anti-catabolic effect is due to the blocking of Ca2-dependent and ubiquitin-proteasome proteolysis.

Can Clenoged 0.04mg provoke side effects? Yes Nevertheless, except for contraindications and compliance with the recommendations, the side effect of the drug has a mild, passing character. Possible side effects include sweating, anxiety, tremor, increased heart rate, increased blood pressure, nausea, loss of appetite; some others.

 DOWNLOAD CLENOGED40 100TABS.pdf